INCRUSE ELLIPTA (Umeclidinium)

What is this medication?

INCRUSE ELLIPTA (Umeclidinium)
Anticholinergic Agent

INCRUSE ELLIPTA (Umeclidinium) is indicated for treatment of chronic pulmonary obstructive disease (COPD).

How does this medication work?

INCRUSE ELLIPTA (Umeclidinium) is a one a day, competitive muscarinic receptor antagonist that reversibly inhibits the action of acetylcholine at type 3 muscarinic (M3) receptors in bronchial smooth muscle causing bronchodilation.

What should I watch for while using this medication?

Before using INCRUSE ELLIPTA (Umeclidinium), make sure your physician is aware of any allergies or medications you currently take, pre-existing medical conditions and activities you perform.  Use with caution in patients with narrow angle glaucoma; may increase intraocular pressure.  Use with caution in patients with urinary retention.

How should I take this medication?

Inhalation: Take 1 inhalation (62.5 mcg) once daily (maximum dose: 1 inhalation/day).

How to Take: For oral inhalation only; administer at the same time each day; there is no need to shake the inhaler. Remove inhaler from sealed pouch immediately prior to first use. Each time the cover of the inhaler is opened, a “click” should be heard and the counter will count down by 1 number; dose is ready to be inhaled. If the counter does not count down as the “click” is heard, the inhaler will not deliver the medicine. Only open inhaler cover when ready for administration; opening and closing the device without inhaling will result in a lost dose; do not close inhaler cover until dose has been inhaled.

What if I miss a dose?

If you miss a dose of medication, try to take it as soon as possible.  However, if it is almost time for your next dose, take only that scheduled dose.  Do not take double or extra doses.

Do not use more than 1 inhalation in a single day.

How should I store this medication?

Keep out of the reach of children at all times. Store at room temperature away from moisture, heat, and light. Keep the inhaler device in the sealed foil tray until ready to start using it.

Discard device 6 weeks after it is removed from the foil tray or when the dose counter reads “0” (whichever comes first).

What are the possible side effects of using this medication?

Tachycardia, toothache, upper abdominal pain, bruise, arthralgia, myalgia, nasopharyngitis, upper respiratory tract infection, cough, pharyngitis, viral upper respiratory tract infection.

Note this is not a complete list of side effects for INCRUSE ELLIPTA (Umeclidinium), only common ones.